Advertisement
Home »

The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.

Jan 15, 2024

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE CONTRIBUTORS

  • Joseph Mazar

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Burnett School of Biological Sciences, The University of Central Florida College of Medicine, Orlando, Florida.

    Jeanne K Brooks

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Matthew Peloquin

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Rosa Rosario

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Emma Sutton

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Matthew Longo

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Burnett School of Biological Sciences, The University of Central Florida College of Medicine, Orlando, Florida.

    Dennis Drehner

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Tamarah J Westmoreland

    Nemours Children’s Hospital, Nemours Parkway, Orlando, Florida.

    Burnett School of Biological Sciences, The University of Central Florida College of Medicine, Orlando, Florida.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement